ヨーロッパの早期毒性検査市場は2023年に約2億5,350万米ドルと評価され、2024年から2032年の予測期間にわたって8.10%を超える健全な成長率で成長すると予想されています。
早期毒性試験は、医薬品開発の連続過程における極めて重要な段階であり、新しい化合物または物質が生体に及ぼす潜在的な悪影響を評価することに重点を置いています。この初期評価は、安全性に関する懸念を特定し、その後の研究開発の取り組みを導くのに役立ちます。早期毒性試験を通じて、研究者はリスクを効果的に管理し、医薬品候補の安全性プロファイルを改良してから、次の開発段階に進むことができます。生命を脅かす疾患に対処することを目的とした研究開発への重点の強化と革新的な医薬品および技術開発への投資の拡大は、ヨーロッパの早期毒性試験市場の成長を支える重要な傾向です。
ヨーロッパの早期毒性試験市場は、新薬や新化学物質の安全性と有効性の評価に対する需要の高まりにより、大幅な成長を遂げています。消費者の安全を確保するために欧州連合が課した厳格な規制により、市場拡大がさらに促進されています。さらに、動物を使わない試験方法に対する需要の高まりにより、従来の動物試験を上回る、より正確で費用対効果の高い in vitro および in silico 試験アプローチの開発が促進されています。市場は、個別化医療の需要の高まりによって支えられており、安全性評価のための臓器チップや 3D 細胞培養などの革新的技術の採用が促進されています。さらに、予測毒性学の需要の急増により、毒性予測のための人工知能や機械学習などの高度な技術が生まれました。しかし、包括的な早期毒性試験に関連する多額の費用は、特に資金が限られている中小企業にとっては大きな障壁となっています。さらに、欧州医薬品庁などの機関による厳格な規制要件により市場参入が遅れ、さらなる成長を妨げる可能性があります。
ヨーロッパの早期毒性試験市場調査で検討されている主要国には、イギリス、ドイツ、フランス、イタリア、スペイン、その他のヨーロッパ諸国が含まれます。2023年には、ドイツがヨーロッパ市場をリードします。この地域では、意識の高まりや有利な償還ポリシーなどの要因により、予測期間中に大幅な成長が見込まれています。毒性試験装置に対する一般の意識の高まりと需要の高まりにより、市場の成長がさらに促進されると予想されます。一方、イギリスは、2024年から2032年の予測期間中に最高のCAGRで成長すると予想されています。
目次
Table of Contents
Chapter 1. Europe Early Toxicity Testing Market Definition and Research Assumptions
1.1. Research Objective
1.2. Market Definition
1.3. Research Assumptions
1.3.1. Inclusion & Exclusion
1.3.2. Limitations
1.3.3. Supply Side Analysis
1.3.3.1. Availability
1.3.3.2. Infrastructure
1.3.3.3. Regulatory Environment
1.3.3.4. Market Competition
1.3.3.5. Economic Viability (Consumer’s Perspective)
1.3.4. Demand Side Analysis
1.3.4.1. Regulatory frameworks
1.3.4.2. Technological Advancements
1.3.4.3. Environmental Considerations
1.3.4.4. Consumer Awareness & Acceptance
1.4. Estimation Methodology
1.5. Years Considered for the Study
1.6. Currency Conversion Rates
Chapter 2. Executive Summary
2.1. Europe Early Toxicity Testing Market Size & Forecast (2022- 2032)
2.2. Regional Summary
2.3. Segmental Summary
2.3.1. By Technique
2.3.2. By Toxicity Endpoint
2.3.3. By End Use
2.4. Key Trends
2.5. Recession Impact
2.6. Analyst Recommendation & Conclusion
Chapter 3. Europe Early Toxicity Testing Market Dynamics
3.1. Market Drivers
3.2. Market Challenges
3.3. Market Opportunities
Chapter 4. Europe Early Toxicity Testing Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model
4.1.7. Porter’s 5 Force Impact Analysis
4.2. PESTEL Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.2.5. Environmental
4.2.6. Legal
4.3. Top investment opportunity
4.4. Top winning strategies
4.5. Disruptive Trends
4.6. Industry Expert Perspective
4.7. Analyst Recommendation & Conclusion
Chapter 5. Europe Early Toxicity Testing Market Size & Forecasts by Technique 2022-2032
5.1. In Vivo
5.2. In Vitro
5.3. In Silico
Chapter 6. Europe Early Toxicity Testing Market Size & Forecasts by Toxicity Endpoint 2022-2032
6.1. Genotoxicity
6.2. Dermal Toxicity
6.3. Skin Toxicity
6.4. Ocular Toxicity
6.5. Phototoxicity
6.6. Others
Chapter 7. Europe Early Toxicity Testing Market Size & Forecasts by Toxicity Endpoint 2022-2032
7.1. Pharmaceutical Industry
7.2. Cosmetic Industry
7.3. Chemical Industry
7.4. Food Industry
7.5. Others
Chapter 8. Europe Early Toxicity Testing Market Size & Forecasts by Country 2022-2032
8.1. U.K. Early Toxicity Testing Market
8.1.1. Technique breakdown size & forecasts, 2022-2032
8.1.2. Toxicity Endpoint breakdown size & forecasts, 2022-2032
8.1.3. End Use breakdown size & forecasts, 2022-2032
8.2. Germany Early Toxicity Testing Market
8.3. France Early Toxicity Testing Market
8.4. Spain Early Toxicity Testing Market
8.5. Italy Early Toxicity Testing Market
8.6. Rest of Europe Early Toxicity Testing Market
Chapter 9. Competitive Intelligence
9.1. Key Company SWOT Analysis
9.1.1. Company 1
9.1.2. Company 2
9.1.3. Company 3
9.2. Top Market Strategies
9.3. Company Profiles
9.3.1. Eurofins Scientific SE
9.3.1.1. Key Information
9.3.1.2. Overview
9.3.1.3. Financial (Subject to Data Availability)
9.3.1.4. Product Summary
9.3.1.5. Market Strategies
9.3.2. Evotec A.G.
9.3.3. Merck KGaA
9.3.4. Company 4
9.3.5. Company 5
9.3.6. Company 6
9.3.7. Company 7
9.3.8. Company 8
9.3.9. Company 9
9.3.10. Company 10
Chapter 10. Research Process
10.1. Research Process
10.1.1. Data Mining
10.1.2. Analysis
10.1.3. Market Estimation
10.1.4. Validation
10.1.5. Publishing
10.2. Research Attributes
List of Tables
TABLE 1. Europe Early Toxicity Testing market, report scope
TABLE 2. Europe Early Toxicity Testing market estimates & forecasts by Country 2022-2032 (USD Million)
TABLE 3. Europe Early Toxicity Testing market estimates & forecasts by Technique 2022-2032 (USD Million)
TABLE 4. Europe Early Toxicity Testing market estimates & forecasts by Toxicity Endpoint 2022-2032 (USD Million)
TABLE 5. Europe Early Toxicity Testing market estimates & forecasts by End Use 2022-2032 (USD Million)
TABLE 6. Europe Early Toxicity Testing market by segment, estimates & forecasts, 2022-2032 (USD Million)
TABLE 7. Europe Early Toxicity Testing market by country, estimates & forecasts, 2022-2032 (USD Million)
TABLE 8. Europe Early Toxicity Testing market by segment, estimates & forecasts, 2022-2032 (USD Million)
TABLE 9. Europe Early Toxicity Testing market by country, estimates & forecasts, 2022-2032 (USD Million)
TABLE 10. Europe Early Toxicity Testing market by segment, estimates & forecasts, 2022-2032 (USD Million)
TABLE 11. Europe Early Toxicity Testing market by country, estimates & forecasts, 2022-2032 (USD Million)
TABLE 12. Europe Early Toxicity Testing market by segment, estimates & forecasts, 2022-2032 (USD Million)
TABLE 13. Europe Early Toxicity Testing market by country, estimates & forecasts, 2022-2032 (USD Million)
TABLE 14. Europe Early Toxicity Testing market by segment, estimates & forecasts, 2022-2032 (USD Million) Europe Early Toxicity Testing market by country, estimates & forecasts, 2022-2032 (USD Million)
TABLE 15. UK Early Toxicity Testing market estimates & forecasts, 2022-2032 (USD Million)
TABLE 16. UK Early Toxicity Testing market estimates & forecasts by segment 2022-2032 (USD Million)
TABLE 17. UK Early Toxicity Testing market estimates & forecasts by segment 2022-2032 (USD Million)
TABLE 18. Germany Early Toxicity Testing market estimates & forecasts, 2022-2032 (USD Million)
TABLE 19. Germany Early Toxicity Testing market estimates & forecasts by segment 2022-2032 (USD Million)
TABLE 20. Germany Early Toxicity Testing market estimates & forecasts by segment 2022-2032 (USD Million)
TABLE 21. France Early Toxicity Testing market estimates & forecasts, 2022-2032 (USD Million)
TABLE 22. France Early Toxicity Testing market estimates & forecasts by segment 2022-2032 (USD Million)
TABLE 23. France Early Toxicity Testing market estimates & forecasts by segment 2022-2032 (USD Million)
TABLE 24. Italy Early Toxicity Testing market estimates & forecasts, 2022-2032 (USD Million)
TABLE 25. Italy Early Toxicity Testing market estimates & forecasts by segment 2022-2032 (USD Million)
TABLE 26. Italy Early Toxicity Testing market estimates & forecasts by segment 2022-2032 (USD Million)
TABLE 27. Spain Early Toxicity Testing market estimates & forecasts, 2022-2032 (USD Million)
TABLE 28. Spain Early Toxicity Testing market estimates & forecasts by segment 2022-2032 (USD Million)
TABLE 29. Spain Early Toxicity Testing market estimates & forecasts by segment 2022-2032 (USD Million)
TABLE 30. RoE Early Toxicity Testing market estimates & forecasts, 2022-2032 (USD Million)
TABLE 31. RoE Early Toxicity Testing market estimates & forecasts by segment 2022-2032 (USD Million)
TABLE 32. RoE Early Toxicity Testing market estimates & forecasts by segment 2022-2032 (USD Million)
TABLE 33. List of secondary sources, used in the study of Europe Early Toxicity Testing Market.
TABLE 34. List of primary sources, used in the study of Europe Early Toxicity Testing Market.
TABLE 35. Years considered for the study.
TABLE 36. Exchange rates considered.
List of figures
FIG 1. Europe Early Toxicity Testing market, research methodology
FIG 2. Europe Early Toxicity Testing market, market estimation techniques
FIG 3. Europe market size estimates & forecast methods.
FIG 4. Europe Early Toxicity Testing market, key trends 2023
FIG 5. Europe Early Toxicity Testing market, growth prospects 2022-2032
FIG 6. Europe Early Toxicity Testing market, porters 5 force model
FIG 7. Europe Early Toxicity Testing market, pestel analysis
FIG 8. Europe Early Toxicity Testing market, value chain analysis
FIG 9. Europe Early Toxicity Testing market by segment, 2022 & 2032 (USD Million)
FIG 10. Europe Early Toxicity Testing market by segment, 2022 & 2032 (USD Million)
FIG 11. Europe Early Toxicity Testing market by segment, 2022 & 2032 (USD Million)
FIG 12. Europe Early Toxicity Testing market by segment, 2022 & 2032 (USD Million)
FIG 13. Europe Early Toxicity Testing market by segment, 2022 & 2032 (USD Million)
FIG 14. Europe Early Toxicity Testing market, Country snapshot 2022 & 2032
FIG 15. Europe Early Toxicity Testing market 2022 & 2032 (USD Million)
FIG 16. Europe Early Toxicity Testing market, company market share analysis (2023)
